
November 2014 Cough & Cold
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Grants Accelerated Approval to Neladalkib for Previously Treated ALK-Positive NSCLC
2
Giredestrant Plus Everolimus Wins FDA Approval in ESR1-Mutated Advanced Breast Cancer
3
FDA Approves Secukinumab as First IL-17 Biologic for Polymyalgia Rheumatica
4
Adrabetadex Becomes First Therapy Shown to Extend Survival in Infantile-Onset Niemann-Pick Disease Type C
5